Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

NeoRx's Verluma approved for U.S. market

Aug. 23, 1996

Conceptus begins clinical testing of STARRT falloposcopy system

Aug. 16, 1996

Home Access HIV testing system cleared for marketing in U.S.

Aug. 16, 1996

BCT launched in U.S.

Aug. 16, 1996

Bard to comarket ProstaScint with Cytogen

Aug. 16, 1996

White Iris leukocyte differential analyzer cleared for U.S. market

Aug. 9, 1996

OncorMed to offer genetic testing for BRC2 mutations

Aug. 9, 1996

BRACAone undergoes beta-site testing in U.S.

Aug. 9, 1996

Cyogen's ProstaScint on its way to FDA approval

July 26, 1996

Oncor obtains license to p43 blood test for early-stage breast cancer

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...